New paper has been published in Talanta. This paper describe how to automate Isotachophoresis chip using microvavle array.
[New Member-2021] Charles joined BMNS Lab for his graduate study!
Welcome to BMNS lab, Charles!
[Publication-2020] Optimization of PDMS Isotachophoresis chip
New paper has been published in Micromachines. This paper describe how to characterize and optimize PDMS based Isotachophoresis chip for sample preconcentration.
[New Member-2020] Multiple undergrad researchers joined BMNS Lab!
Welcome Sabrina, Nick, and Chase to BMNS lab!
Ali and Zach will give presentations at IMECE 2019!
Ali will present our collaborative optical cavity biosensor work and Zach will give a podium presentation regarding a molecular stamping technique at IMECE19!
[New Member-2019] Minju joined BMNS Lab!
Welcome to BMNS lab!
Zach and Dr. Kim will give presentations at microTAS 2019!
Zach will talk about our collaborative Enceladus Organic Analyzer project and Dr. Kim behalf of Ali will present a state-of-art biosensing platform for cardiac panel screenings at Basel, Switzerland.
Ali will give a poster presentation at BMES 2019!
Great works by combining capillary Microfluidics and impedance biosensors for biomarker screenings!
Recruit undergraduate and graduate researchers and postdoctoral scholars
BMNS Lab at the U is hiring undergraduate and graduate students and postdoctoral scholars to work on developing organ chips, various biosensors, and integrated microfluidic systems. Please send a coverletter and CV to Dr. Kim (jkim@mech.utah.edu).
Creating a Cornea-On-A-Chip
EyeWorld News and Opinion Research Highlight Mircorengineering Ophthalmic Drug Testing – December 2018
Mechanical engineering associate professor Jungkyu (Jay) Kim‘s research while an assistant professor in the Department of Mechanical Engineering at Texas Tech University, Lubbock, Texas, microengineered human cornea-on-a-chip. This chip could speed the ophthalmic drug development process since it would allow for the simultaneous testing of many different types of ocular drugs.
Read the full story here by Maxine Lipner, EyeWorld Senior Contributing Writer